Derniers essais

EudraCT Number: 2004-000882-36

Sponsor Protocol Number: PAD20001

Start Date: 2004-08-05

Sponsor Name: GlaxoSmithKine Research & Development Limited

Full Title: A multi-centre, two-staged with interim analysis, parallel, randomised, double blind, placebo-controlled, dose ranging study of the safety, tolerability, and effects on plasma high-density lipoprot...

Medical condition: Treatment of dyslipidaemia

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) FI (Completed) LT (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2004-000432-85

Sponsor Protocol Number: BAP00091

Start Date: 2004-08-05

Sponsor Name: Basilea Pharmaceutica Ltd

Full Title: Follow-up Efficacy and Safety Study of BAL4079 in the Treatment of Chronic Hand Dermatitis Refractory to Topical Therapy

Medical condition: Severe Chronic Hand Dermatitis (CHaD) Refractory to Topical Therapy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) CZ (Completed) GB (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2004-000211-26

Sponsor Protocol Number: D5890L00007

Start Date: 2004-08-04

Sponsor Name: AstraZeneca AB

Full Title: A comperative, placebo-controlled, doubleblind, double dummy, cross over, single center phase IIIb study between formoterol alone and the fixed combination of formoterol and budesonide on airway re...

Medical condition: Patient with stable and mild allergic asthma.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: View results

EudraCT Number: 2004-000996-33

Sponsor Protocol Number: A6121122

Start Date: 2004-08-04

Sponsor Name: Pfizer AB

Full Title: A global phase IV, double-blind, placebo-controlled, randomized trial to evaluate the effectiveness of Detrusitol SR 4 mg on Patient's Perception of Bladder Condition (PPBC).

Medical condition: Overactive bladder syndrome (OAB)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) GB (Completed) IT (Completed) DK (Completed)

Trial results: View results

EudraCT Number: 2004-000248-25

Sponsor Protocol Number: CZOL446O2306

Start Date: 2004-08-04

Sponsor Name: Novartis Pharma AG

Full Title: A multinational, multicenter, randomized, double-blind, double-dummy, stratified, active controlled parallel group study comparing the efficacy and safety of intravenous zoledronic acid, 5 mg once ...

Medical condition: corticosteroid induced osteoporosis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) CZ (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-000985-12

Sponsor Protocol Number: AVA100468

Start Date: 2004-08-03

Sponsor Name: GlaxoSmithKline R&D Limited

Full Title: An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease.

Medical condition: Mild to moderate Alzheimer's Disease

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-001197-10

Sponsor Protocol Number: CVAH631C2302

Start Date: 2004-08-03

Sponsor Name: Novartis Pharmaceuticals Corporation

Full Title: A double-blind, randomized, multi-center active-controlled, parallel-group study comparing the combination of valsartan 320 mg plus hydrochlorothiazide 12.5 mg and valsartan 320 mg plus hydrochlor...

Medical condition: Mild to moderate hypertension

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000243-23

Sponsor Protocol Number: Hx-CD4-109

Start Date: 2004-08-03

Sponsor Name: Genmab A/S

Full Title: An Open-Label Therapeutic Exploratory Clinical Trial of HuMax-CD4, a Fully Human Monoclonal Anti-CD4 Antibody, in Patients with refractory or relapsed Non-Cutaneous CD4+ T-Cell Lymphoma

Medical condition: The mature non-cutaneous T-cell lymphomas expressing the CD4 molecule are the object of this protocol. 1.Peripheral T-cell lymphoma (PTCL) unspecified 2.Angioimmunnoblastic T-cell lymphoma 3.Anapl...

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10042971		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) DK (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000580-10

Sponsor Protocol Number: H6D-HL-LVGD

Start Date: 2004-08-03

Sponsor Name: Oy Eli Lilly Finland Ab

Full Title: Effect of Tadalafil on the Quality of Life and Sexual Life Satisfaction in Erectile Dysfunction (ED) Patients Previously Treated with other Oral ED therapy

Medical condition: Erectile dysfunction

Disease:	Version	SOC Term	Classification Code	Term	Level
			10061461

Population Age: Adults, Elderly

Gender: Male

Trial protocol: FI (Completed)

Trial results: View results

EudraCT Number: 2004-001449-13

Sponsor Protocol Number: XM02-04-INT

Start Date: 2004-08-03

Sponsor Name: BioGeneriX AG

Full Title: Safety and Efficacy of XM 02 in patients with Non-Hodgkin-Lymphoma receiving chemotherapy.

Medical condition: Patients with Non-Hodgkin-Lymphoma receiving chemotherapy and developing Neutropenia due to chemotherapy.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) LT (Completed)

Trial results: (No results available)

Derniers essais

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue